Elevated fecal peptidase D at onset of colitis in Galphai2-/- mice, a mouse model of IBD.

by Daniel Bergemalm, Robert Kruse, Maria Sapnara, Jonas Halfvarson, Elisabeth Hultgren Hörnquist
Published 2017-01-01

Subphenotypes of inflammatory bowel disease are characterized by specific serum protein profiles.

by Erik Andersson, Daniel Bergemalm, Robert Kruse, Gunter Neumann, Mauro D'Amato, Dirk Repsilber, Jonas Halfvarson
Published 2017-01-01

Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients.

by Karin Forsberg, P Andreas Jonsson, Peter M Andersen, Daniel Bergemalm, Karin S Graffmo, Magnus Hultdin, Johan Jacobsson, Roland Rosquist, Stefan L Marklund, Thomas Brännström
Published 2010-07-01

Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study

by Carl Eriksson, Sara Rundquist, Vyron Lykiardopoulos, Ruzan Udumyan, Per Karlén, Olof Grip, Charlotte Söderman, Sven Almer, Erik Hertervig, Jan Marsal, Jenny Gunnarsson, Carolina Malmgren, Jenny Delin, Hans Strid, Mats Sjöberg, David Öberg, Daniel Bergemalm, Henrik Hjortswang, Jonas Halfvarson
Published 2021-07-01